Literature DB >> 10692178

Micropapillary variant of transitional cell carcinoma of the ureter.

Y L Oh1, K R Kim.   

Abstract

Micropapillary variant of transitional cell carcinoma (TCC) is a rare entity, having a distinct micropapillary component mimicking papillary serous carcinoma of the ovary and has been reported exclusively in the urinary bladder. We experienced a case of micropapillary variant of TCC in the ureter. The tumor showed a predominant proportion of micropapillary component and accompanied a TCC in situ lesion and a high-grade TCC. A metastatic lesion in the regional lymph node also showed an entirely micropapillary pattern. Initially, our case was confused with adenocarcinoma, especially metastatic, because the micropapillary architecture resembled an abortive glandular structure and tumor cell nests were predominantly located in empty spaces mimicking vascular invasion. The patient died with peritoneal metastases 20 months after the initial diagnosis. We report the first case of a micropapillary variant of TCC occurring in the ureter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692178     DOI: 10.1046/j.1440-1827.2000.00997.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  8 in total

1.  Clinicopathological features of stomach cancer with invasive micropapillary component.

Authors:  Takeo Fujita; Naoto Gotohda; Yuichiro Kato; Takahiro Kinoshita; Shinichiro Takahashi; Masaru Konishi; Hiroyuki Daiko; Mitsuyo Nishimura; Takeshi Kuwata; Atsushi Ochiai; Taira Kinoshita
Journal:  Gastric Cancer       Date:  2011-10-12       Impact factor: 7.370

2.  Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.

Authors:  Alexandra Masson-Lecomte; Pierre Colin; Gregory Bozzini; Laurent Nison; Alexandre de La Taille; Eva Comperat; Marc Zerbib; François Rozet; Xavier Cathelineau; Antoine Valeri; Alain Ruffion; Laurent Guy; Stéphane Droupy; Olivier Cussenot; Morgan Rouprêt
Journal:  World J Urol       Date:  2013-08-02       Impact factor: 4.226

3.  Micropapillary carcinoma of the urinary bladder: a case report and review of the literature.

Authors:  Amel Trabelsi; Wided Stita; Rammeh Soumaya; Sarra Mestiri; Mehdi Jaidene; Moncef Mokni; Sadok Korbi
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

4.  Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.

Authors:  Alexandra Masson-Lecomte; Evanguelos Xylinas; Morgane Bouquot; Mathilde Sibony; Yves Allory; Eva Comperat; Marc Zerbib; Alexandre de la Taille; Morgan Rouprêt
Journal:  World J Urol       Date:  2014-09-02       Impact factor: 4.226

5.  Micropapillary component of urothelial carcinoma detected in transurethral resection of bladder tumor (TUR-BT) tissues: a case report.

Authors:  Yuji Ohtsuki; Kenji Ochi; Yuhei Okada; Miyuki Kato; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

6.  Small cluster invasion: a possible link between micropapillary pattern and lymph node metastasis in pT1 lung adenocarcinomas.

Authors:  Takehito Kawakami; Kazuki Nabeshima; Makoto Hamasaki; Akinori Iwasaki; Takayuki Shirakusa; Hiroshi Iwasaki
Journal:  Virchows Arch       Date:  2008-11-11       Impact factor: 4.064

7.  Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database.

Authors:  Srinivas Vourganti; Andrew Harbin; Eric A Singer; Brian Shuch; Adam R Metwalli; Piyush K Agarwal
Journal:  J Cancer       Date:  2013-05-06       Impact factor: 4.207

8.  Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine.

Authors:  Gavin M Wright; Hongdo Do; Jonathan Weiss; Naveed Z Alam; Vivek Rathi; Marzena Walkiewicz; Thomas John; Prudence A Russell; Alexander Dobrovic
Journal:  Oncotarget       Date:  2014-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.